기사 리스트형 웹진형 타일형 Alectinib curbs CNS metastases in some with advanced lung cancer NEW YORK (Reuters Health)By David Douglas - Alectinib (Alecensa, Genentech) shows efficacy against CNS metastases in crizotinib-refractory patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC), according to pooled data from two phase II studies sponsored by Hoffm 2016-10-15 09:45 처음처음1끝끝
